Different effects of the serotonergic agonists buspirone and sumatriptan on the posterior pituitary hormonal responses to hypoglycemia in humans

@article{Chiodera1996DifferentEO,
  title={Different effects of the serotonergic agonists buspirone and sumatriptan on the posterior pituitary hormonal responses to hypoglycemia in humans},
  author={P. Chiodera and R. Volpi and L. Capretti and G. Caffarri and M. Magotti and V. Coiro},
  journal={Neuropeptides},
  year={1996},
  volume={30},
  pages={187-192}
}
The responses of serum oxytocin (OT) and vasopressin (AVP) to the serotonergic HT1A agonist buspirone (15 mg p.o.) or the HTD1 agonist sumatriptan (6 mg injected subcutaneously) were evaluated in 7 normal men either in basal conditions or during an insulin (0.15 iu/kg as an i.v. bolus) tolerance test (ITT). Neither buspirone nor sumatriptan administration modified the basal secretion of AVP and OT. Stimulation of 5HT-1D receptors with sumatriptan was unable to change neither AVP nor OT response… Expand
5 Citations
5-HT3 serotonergic receptor mediation of hypoglycemia-induced arginine-vasopressin but not oxytocin secretion in normal men
TLDR
5-HT3 serotonergic receptors at least partially mediate the AVP response to hypoglycemia, without modifying the simultaneous OT response, and 5-HT2 receptors do not appear to be involved in the control of basal posterior pituitary hormone secretions. Expand
Effect of serotonergic system on AVP secretion induced by physical exercise
TLDR
Data demonstrate that 5-HT3 serotonergic receptors at least partially mediate the AVP response to physical exercise, and 5- HT1A and5-HT1D seroton allergic receptors do not appear to be involved in the control of AVP secretion during exercise. Expand
Drugs and Pituitary Function
TLDR
Effects of various other substances and hormones are discussed in this chapter, and acute administration of opiates has profound and generally consistent effects on human pituitary function. Expand
Forebrain Pathways Mediating Stress-Induced Hormone Secretion
TLDR
Although a diverse group of stressors initiate similar increases in ACTH, renin, prolactin, and oxytocin, the specific neural circuits and neurotransmitter systems involved in these responses differ for each neuroendocrine system and stressor category. Expand
Dynamic regulation of oxytocin neuronal circuits in the sequential processes of prosocial behavior in rodent models
Abstract The expression of positive social (i.e., prosocial) behavior is governed by a multitude of sensory and cognitive abilities to identify and recognize key features of potential socialExpand

References

SHOWING 1-10 OF 21 REFERENCES
THE EFFECT OF KETANSERIN, A SPECIFIC SEROTONIN ANTAGONIST ON THE PRL, GH, ACTH AND CORTISOL RESPONSES TO HYPOGLYCAEMIA IN NORMAL SUBJECTS
TLDR
It is suggested that serotonin, probably acting through 5HT2 receptors, is involved in the stimulation of prolactin and ACTH release but not in the release of growth hormone, during insulin induced hypoglycaemia. Expand
Effect of serotonin on vasopressin release: a comparison to corticosterone, prolactin and renin.
TLDR
The data demonstrate that vasopressin levels are elevated briefly following 5-HT i.c.v., consistent with the pharmacologic profile of the early cardiovascular response. Expand
Increase by naloxone of arginine vasopressin and oxytocin responses to insulin-induced hypoglycemia in obese men
TLDR
Data indicate that an abnormal activity of endogenous opioids might account for the hypothalamic posterior pituitary dysfunction, which is responsible for the low AVP and OT responses to insulin-induced hypoglycemia in obesity. Expand
Long-term fluoxetine, but not desipramine, inhibits the ACTH and oxytocin responses to the 5-HT1A agonist, 8-OH-DPAT, in male rats
TLDR
It is suggested that chronic, but not acute, exposure to fluoxetine decreases 5-HT1A receptor function, which is not seen in rats chronically exposed to DMI. Expand
Hypoglycemia-induced arginine vasopressin and oxytocin release is mediated by glucoreceptors located inside the blood-brain barrier.
TLDR
Since glucose, but not fructose, crosses the blood-brain barrier (BBB), the posterior pituitary hormone responses to hypoglycemia appear to be generated by stimulations of glucosensitive areas located inside the BBB. Expand
Pharmacological characterization of serotonin receptor subtypes involved in vasopressin and plasma renin activity responses to serotonin agonists.
TLDR
It is suggested that BP and PRA but not vasopressin responses are mediated by 5-HT2 receptors, most likely by5-HT1C receptors. Expand
A Preliminary Neuroendocrine Study with Buspirone in Major Depression
TLDR
The findings support a role for the serotonin-la receptor in the etiology of MDD, specifically at the postsynaptic site, and support the idea that prolactin response to buspirone is blunted in depressed patients. Expand
Inhibition of hypoglycemia-induced cortisol secretion by the serotonin antagonist cyproheptadine.
TLDR
The plasma glucose levels in control insulin tolerance tests and the posttreatment tests indicated a comparable stimulus for cortisol secretion, and the role of hypothalamic serotonin in cortisol secretion was investigated in man. Expand
Insulin-induced hypoglycemia stimulates corticotropin-releasing factor and arginine vasopressin secretion into hypophysial portal blood of conscious, unrestrained rams.
TLDR
The results suggest that when the hypoglycemia is moderate, CRF is the main factor triggering ACTH release, and that the increased AVP secretion potentiates the stimulatory effect of CRF. Expand
Effect of the serotonin reuptake inhibitor fluoxetine on corticotropin-releasing factor and vasopressin secretion into hypophysial portal blood
TLDR
The data suggest that increased secretion of ACTH induced by fluoxetine is mediated, at least in part, by an increase in the hypothalamic secretion of both CRF and AVP. Expand
...
1
2
3
...